What is AXSM's current stock price?

As of now, AXSM is trading at $174.14, with a daily change of -1.62%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

AXSM Stock Analysis & IQ Rating | Axsome Therapeutics

AXSM

Axsome Therapeutics

$174.14

-$2.87 | -1.62%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

alert Latest Updates

Bullish.Bets Yesterday at 10:54

– Upside 160.20%
Black Rifle Coffee is trading near its 52-week low while analysts raised the average target to $2.55. With expectations washed out and volume holding steady, this is a classic high-risk turnaround set...

AXSM Stock IQ

Login to see Axsome Therapeutics (AXSM) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

AXSM Target Price

Login to display

Strengths

AXSM Rewards

Upgraded on attractively valued

AXSM Price Performance

$148 (+17.66%)

$131.6 (+32.33%)

$118.51 (+46.94%)

$106.46 (+63.57%)

1year

6month

3month

1month

AXSM Risk Level

AXSM has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

AXSM Analysts Opinion

AXSM overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

AXSM Analysts Opinion

AXSM Analysts opinion is negative and it remained unchanged from the past 3 months

AXSM Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

100%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

AXSM Street Sentiment

AXSM Street Sentiment is extremely bullish and have positive views on the near-term outlook

AXSM Performance Sentiment

Sentiments overview associated with AXSM events and the stock performance.

100%

0%

Positive

Negative

14 out of 14
events present

0 out of 14
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$177.01

Resistance
Price

$146.87

Current Price Range

$182.64

Show methods +

Linked to AXSM

IQ

Close Price

Change

TEVA

4.43

32.35

-0.90%

Recently Viewed

Close Price

Change

AXSM

Axsome Therapeutics

174.14

-1.62%

KBH

KB Home

62.24

+0.99%

LEXX

Lexaria Bioscience

0.73

-6.53%

AMX

America Movil

19.89

-3.16%

LUMN

Lumen Technologies

8.65

+5.36%

AXSM Latest Analysis +

Why Axsome Therapeutics (AXSM) is a Top Momentum Stock for the Long-Term. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.

Today

$174.14 | -1.62%

Momentum

Axsome Therapeutics (AXSM) Price Target Increased by 13.75% to 207.38. The average one-year price target for Axsome Therapeutics (NasdaqGM:AXSM) has been revised to $207.38 / share. This is an increase of 13.75% from the prior estimate of $182.31 dated December 18 2025. The price target is an average of many targets provided by

Wed Jan 14, 2026

$177.01 | +1.54%

Potential

Axsome Therapeutics Preliminary Q4 Net Product Revenue Up 65% . (RTTNews) - Axsome Therapeutics Inc. (AXSM) said based on preliminary financial information Axsome expects total product revenue to be approximately $196.0 million for the fourth quarter representing 65% annual growth compared to the fourth quarter 2024. The company expects t

Mon Jan 12, 2026

$176.82 | +4.39%

Earnings

Axsome Therapeutics announces prelim Q4 FY revenue above estimates.

Mon Jan 12, 2026

$176.82 | +4.39%

Earnings

2 Healthcare Stocks to Buy for 2026 and Beyond. Key PointsAxsome Therapeutics and Exelixis are generating solid revenue with their current lineups.

Thu Jan 8, 2026

$167.55 | -1.84%

Potential

Axsome Therapeutics Stock Jumps After FDA Grants Priority Review For Alzheimers Agitation Drug. Axsome stock jumped Wednesday after the biotech firm said its Alzheimers disease agitation drug will get a priority review.The post Axsome Therapeutics Stock Jumps After FDA Grants Priority Review For Alzheimer'.s Agitation Drug appeared first on Investor'.s Business Daily.

Wed Dec 31, 2025

$182.64 | +22.75%

Activity

Momentum

Why Axsome Therapeutics Stock Rocketed Higher to End 2025. Key PointsAxsome just received priority review designation for its most important drug.

Wed Dec 31, 2025

$182.64 | +22.75%

Momentum

Axsome Shares Jump 19% After FDA Acceptance Of AX-S12 Priority Review And Positive Pre-NDA Feedback . (RTTNews) - Axsome Therapeutics Inc. (AXSM) shares rose 19.37% trading at $177.62 up $28.83 after the company announced that the FDA accepted its New Drug Application (NDA) for AX-S12 with Priority Review and shared positive insights from a recent FDA pre-NDA meeting regardin

Wed Dec 31, 2025

$182.64 | +22.75%

Momentum

Axsome Therapeutics Advances Toward NDA Submission For AXS-12 In Narcolepsy . (RTTNews) - Axsome Therapeutics Inc. (AXSM) announced that it has received formal pre-New Drug Application (NDA) meeting minutes from the United States Food and Drug Administration (FDA). The FDA feedback supports the companys planned NDA submission for AXS-12 in narcolepsy. AXS-12 (reb

Wed Dec 31, 2025

$182.64 | +22.75%

Activity

FDA Accepts Axsomes SNDA For AXS-05 In Alzheimers Agitation With Priority Review . (RTTNews) - Axsome Therapeutics Inc. (AXSM) announced that the United States Food and Drug Administration has accepted for filing its supplemental New Drug Application (NDA) for AXS-05 (dextromethorphan HBr and bupropion HCl) for the treatment of agitation associated with Alzheimers dis

Wed Dec 31, 2025

$182.64 | +22.75%

Activity

FAQ About AXSM Stock Insights

What is AXSM current stock price?

What are AXSM stock strengths?

What is AXSM Risk Level?

What is AXSM market cap and volume?

What is AXSM current Stock IQ?

Should I buy AXSM stock right now?

Is AXSM a Strong Buy right now?

What does a 'Strong Buy' rating mean for AXSM?

What does a 'Strong Sell' rating mean for AXSM?

What factors influence AXSM's Stock IQ?

Explore our AXSM Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored AXSM Stock Strategies
Effective Risk Management

FIND US ON

Receive our AXSM Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

AXSM

Axsome Therapeutics

Set Alerts

Current Price

$174.14

-$2.87 | -1.62%

52W High

$184.4

MKT CAP

$8.77B

52W Low

$86.99

VOL

$650.52K

P/E Ratio

N/A

AVG VOL

$692.15K

RSI

62.15

TREND

Uptrend

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

AXSM Stock IQ

Login to unlock Axsome Therapeutics (AXSM) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Target Price

Login to display

Stock Insights

Strengths

AXSM Rewards

Upgraded on attractively valued

Linked to AXSM

Symbol

IQ

Close

Change

TEVA

4.43

32.35

-0.90%

AXSM Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

100%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

AXSM Street Sentiment

AXSM Street Sentiment is extremely bullish and have positive views on the near-term outlook

AXSM Risk Level

AXSM has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

AXSM Performance Sentiment

Sentiments overview associated with AXSM events and the stock performance.

100%

0%

Positive

Negative

14 out of 14
events present

0 out of 14
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$177.01

Resistance
Price

$146.87

Current Price Range

$182.64

Show methods +

AXSM Latest Analysis

Bullish.Bets Yesterday at 10:54

– Upside 160.20%
Black Rifle Coffee is trading near its 52-week low while analysts raised the average target to $2.55. With expectations washed out and volume holding steady, this is a classic high-risk turnaround set...

Why Axsome Therapeutics (AXSM) is a Top Momentum Stock for the Long-Term. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.

Today

$174.14 | -1.62%

Momentum

Axsome Therapeutics (AXSM) Price Target Increased by 13.75% to 207.38. The average one-year price target for Axsome Therapeutics (NasdaqGM:AXSM) has been revised to $207.38 / share. This is an increase of 13.75% from the prior estimate of $182.31 dated December 18 2025. The price target is an average of many targets provided by

Wed Jan 14, 2026

$177.01 | +1.54%

Potential

Axsome Therapeutics Preliminary Q4 Net Product Revenue Up 65% . (RTTNews) - Axsome Therapeutics Inc. (AXSM) said based on preliminary financial information Axsome expects total product revenue to be approximately $196.0 million for the fourth quarter representing 65% annual growth compared to the fourth quarter 2024. The company expects t

Mon Jan 12, 2026

$176.82 | +4.39%

Earnings

Axsome Therapeutics announces prelim Q4 FY revenue above estimates.

Mon Jan 12, 2026

$176.82 | +4.39%

Earnings

2 Healthcare Stocks to Buy for 2026 and Beyond. Key PointsAxsome Therapeutics and Exelixis are generating solid revenue with their current lineups.

Thu Jan 8, 2026

$167.55 | -1.84%

Potential

Axsome Therapeutics Stock Jumps After FDA Grants Priority Review For Alzheimers Agitation Drug. Axsome stock jumped Wednesday after the biotech firm said its Alzheimers disease agitation drug will get a priority review.The post Axsome Therapeutics Stock Jumps After FDA Grants Priority Review For Alzheimer'.s Agitation Drug appeared first on Investor'.s Business Daily.

Wed Dec 31, 2025

$182.64 | +22.75%

Activity

Momentum

Why Axsome Therapeutics Stock Rocketed Higher to End 2025. Key PointsAxsome just received priority review designation for its most important drug.

Wed Dec 31, 2025

$182.64 | +22.75%

Momentum

Axsome Shares Jump 19% After FDA Acceptance Of AX-S12 Priority Review And Positive Pre-NDA Feedback . (RTTNews) - Axsome Therapeutics Inc. (AXSM) shares rose 19.37% trading at $177.62 up $28.83 after the company announced that the FDA accepted its New Drug Application (NDA) for AX-S12 with Priority Review and shared positive insights from a recent FDA pre-NDA meeting regardin

Wed Dec 31, 2025

$182.64 | +22.75%

Momentum

Axsome Therapeutics Advances Toward NDA Submission For AXS-12 In Narcolepsy . (RTTNews) - Axsome Therapeutics Inc. (AXSM) announced that it has received formal pre-New Drug Application (NDA) meeting minutes from the United States Food and Drug Administration (FDA). The FDA feedback supports the companys planned NDA submission for AXS-12 in narcolepsy. AXS-12 (reb

Wed Dec 31, 2025

$182.64 | +22.75%

Activity

FDA Accepts Axsomes SNDA For AXS-05 In Alzheimers Agitation With Priority Review . (RTTNews) - Axsome Therapeutics Inc. (AXSM) announced that the United States Food and Drug Administration has accepted for filing its supplemental New Drug Application (NDA) for AXS-05 (dextromethorphan HBr and bupropion HCl) for the treatment of agitation associated with Alzheimers dis

Wed Dec 31, 2025

$182.64 | +22.75%

Activity

Discover AXSM Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of AXSM. We're here to help you make informed investment decisions today.

FIND US ON

Receive our AXSM Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

AXSM Stock trends

AXSM Stock performance

AXSM Stock analysis

AXSM investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing AXSM

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing AXSM

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

AXSM Stock Analysis & IQ Rating | Axsome Therapeutics

AXSM Stock IQ

AXSM Target Price

AXSM Risk Level

AXSM Analysts Opinion

AXSM Street Sentiment

AXSM Performance Sentiment

Technical Price Levels

Explore our AXSM Stock insights

Receive our AXSM Daily Alerts

AXSM Street Sentiment

AXSM Risk Level

Technical Price Levels

Discover AXSM Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of AXSM. We're here to help you make informed investment decisions today.

Receive our AXSM Daily Alerts

AXSM Alerts